PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

esketamine

Verify with FDA → · CMS NADAC pricing →

Brand names: Spravato

NMDA Receptor Antagonist (Nasal Spray) Rx

Spravato is a nasal spray medicine used to treat depression. It contains esketamine and affects certain receptors in the brain.

Drug Pricing (NADAC)

Brand Price

$373.45/unit

Generic Available

No

JANSSEN PHARMS

Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →

What it does

Spravato is used to treat treatment-resistant depression in adults.

Common side effects

Feeling disconnected from yourself or your surroundings, Dizziness, Nausea

Key warnings

Spravato can cause sleepiness, feeling disconnected, and breathing problems.

How It Works

Spravato is a type of medicine called an NMDA receptor antagonist. It works by affecting certain receptors in the brain. These receptors are involved in regulating mood and emotions.

How to Take It

Spravato is given as a nasal spray by a healthcare provider. You will spray it into your nose. You will be watched for at least 2 hours after each dose. Avoid food for 2 hours and liquids for 30 minutes before taking Spravato. If you use a nasal spray for allergies, use it 1 hour before Spravato.

Pregnancy & Breastfeeding

Spravato may harm an unborn baby. Talk to your doctor about pregnancy planning and birth control. Breastfeeding is not recommended while using Spravato.

Missed Dose

Spravato is given by a healthcare provider, so you are unlikely to miss a dose. If you miss an appointment, call your doctor as soon as possible.

Storage

Store Spravato at room temperature, between 68° to 77°F.

Side Effects (from patient reports)

Based on 12,545 FDA adverse event reports.

Feeling disconnected from yourself or your surroundings
3,351
Sleepiness
2,465
Thoughts of suicide
1,233
The medicine is not working
1,032
Feeling sick to your stomach
876
Feeling sad or hopeless
808
Problem with the dose of the medicine
709
Needing to be in the hospital
702
High blood pressure
688
Feeling worried or nervous
681

FDA Adverse Event Report Analysis

Detailed analysis of 15,846 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2015–2025.

Total Reports

15,846

Death-Related Reports

641

Hospitalization Reports

2,714

Top Indication

Depression

Gender Distribution

Female 8,844 (66%)
Male 4,563 (34%)

Age Distribution

0–17 881
18–44 4,243
45–64 3,916
65–74 1,107
75+ 218

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
1 DISSOCIATION 3,351
2 SEDATION 2,465
3 SUICIDAL IDEATION 1,233
4 DRUG INEFFECTIVE 1,032
5 NAUSEA 876
6 DEPRESSION 808
7 PRODUCT DOSE OMISSION ISSUE 709
8 HOSPITALISATION 702
9 HYPERTENSION 688
10 ANXIETY 681
11 VOMITING 643
12 DIZZINESS 597
13 BLOOD PRESSURE INCREASED 518
14 FEELING ABNORMAL 455
15 OFF LABEL USE 365

Reactions in Death Reports

DEATH 291
COMPLETED SUICIDE 229
DRUG INEFFECTIVE 19
ROAD TRAFFIC ACCIDENT 15
PRODUCT DOSE OMISSION ISSUE 14
OVERDOSE 13
SUICIDAL IDEATION 13
DEPRESSION 12
SEDATION 11
DISSOCIATION 10

Reactions in Hospitalization Reports

HOSPITALISATION 696
SUICIDAL IDEATION 329
DISSOCIATION 313
SEDATION 207
DEPRESSION 198
SUICIDE ATTEMPT 172
HYPERTENSION 117
DRUG INEFFECTIVE 112
ANXIETY 89
PRODUCT DOSE OMISSION ISSUE 77

Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

Spravato can cause sleepiness, feeling disconnected, and breathing problems. You will be monitored for these side effects. Spravato has the potential for abuse and misuse. Spravato may increase suicidal thoughts and behaviors in young adults. Spravato is only available through a special program.

Known Drug Interactions

7.2 Psychostimulants Concomitant use with psychostimulants (e.g., amphetamines, methylphenidate, modafinil, armodafinil) may increase blood pressure [see Warnings and Precautions (5.7) ] .

Mechanism: Taking these two medicines together can cause your blood pressure to go up higher than usual.

What to do: Your healthcare provider should check your blood pressure regularly while you are using both medications.

Common Questions

Can Spravato prevent suicide?
No, Spravato has not been shown to prevent suicide.
Can I drive after taking Spravato?
No, do not drive or operate machinery until the next day after a restful sleep.
What if my blood pressure is high?
Your doctor will check your blood pressure before and after each dose. They will decide if Spravato is right for you.
Is Spravato safe for children?
No, Spravato is not approved for use in children.
What should I avoid before taking Spravato?
Avoid food for 2 hours and liquids for 30 minutes before taking Spravato.
Can I take other medicines with Spravato?
Tell your doctor about all the medicines you take, including over-the-counter drugs.
How long will I be monitored after taking Spravato?
You will be monitored for at least 2 hours after each dose.
What if I feel sleepy after taking Spravato?
Tell your healthcare provider if you feel sleepy or have trouble breathing.
How is Spravato supplied?
Spravato comes as a nasal spray in a special device.
What does Spravato contain?
Each nasal spray device delivers two sprays containing a total of 28 mg of esketamine.
What are the common side effects of esketamine?
The most commonly reported side effects of esketamine include Feeling disconnected from yourself or your surroundings, Dizziness, Nausea, Sleepiness, Spinning sensation. Based on 12,545 FDA adverse event reports. Always consult your healthcare provider about potential side effects.
Does esketamine interact with other medications?
Yes, esketamine has 1 known drug interactions. Notable interactions include methylphenidate. Always inform your doctor about all medications you are taking.
What drug class is esketamine?
esketamine belongs to the NMDA Receptor Antagonist (Nasal Spray) drug class. It requires a prescription (Rx). Spravato is used to treat treatment-resistant depression in adults.
Is esketamine safe during pregnancy?
Spravato may harm an unborn baby. Talk to your doctor about pregnancy planning and birth control. Always consult your healthcare provider before using any medication during pregnancy or breastfeeding.

Related Medications in NMDA Receptor Antagonist (Nasal Spray)

Other drugs grouped near esketamine — same-class peers and common alternatives.

Compare esketamine vs acamprosate side-by-side →

Medication Guides

Related Health & Safety Data

Save on esketamine

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for esketamine

The FDA label for esketamine (sold under brand names such as Spravato) classifies it as a prescription-only medication in the NMDA Receptor Antagonist (Nasal Spray) class. Spravato is used to treat treatment-resistant depression in adults. Official labeling lists 12 commonly reported side effects, including Feeling disconnected from yourself or your surroundings, Dizziness, Nausea.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 12,545 voluntary reports. The database also lists 1 documented drug interaction derived from FDA labeling, with the top-flagged interaction rated minor severity. NADAC pricing from CMS.

Report counts do not establish causation — a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice — always consult a licensed healthcare provider before starting, stopping, or changing any medication.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.

Last updated: August 26, 2025

All federal data sources used on this page